1-(3,4-dihydroxyphenyl)-2-(1-imidazolyl)ethanone has been researched along with Seizures in 1 studies
*Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leonardi, A; Magistretti, MJ; Nardi, D; Pennini, R; Portioli, F; Subissi, A; Tajana, A | 1 |
1 other study(ies) available for 1-(3,4-dihydroxyphenyl)-2-(1-imidazolyl)ethanone and Seizures
| Article | Year |
|---|---|
Synthesis and anticonvulsant activity of N-(benzoylalkyl)imidazoles and N-(omega-phenyl-omega-hydroxyalkyl)imidazoles.
Topics: Animals; Anticonvulsants; Female; Imidazoles; Male; Mice; Phenobarbital; Phenytoin; Seizures; Structure-Activity Relationship | 1981 |